Cancer BiologybioRxivPreprint
PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer
Sahar F. Bannoura, Husain Yar Khan, Amro Aboukameel…·Asfar S. Azmi
This study shows that combining PCNA inhibitor AOH1996 with KRAS inhibitors enhances antitumor activity in pancreatic cancer models.
2 citations